Antibody–drug conjugates (ADCs) represent a novel and evolving class of antineoplastic
agents, constituted by monoclonal antibody linked to biologically active drugs, delivering …

PURPOSE: The financial toxicity of anticancer drugs is well-documented, but little is known
about the costs of drugs used to manage cancer-associated symptoms. METHODS: We …

Oral mucositis (OM) is a debilitating complication affecting roughly 70% of head and neck
cancer patients receiving chemotherapy and/or radiation treatment. No broadly effective …

Simple Summary Head and neck cancer is the seventh-most prevalent cancer worldwide.
Despite advances in treatment, many patients suffer from chemoradiation-induced oral …

The oral cavity is a portal into the digestive system, which exhibits unique sensory
properties. Like facial skin, the oral mucosa needs to be exquisitely sensitive and selective …

Acute lymphocytic leukemia (ALL) is the most frequent form of all childhood leukemias,
mostly affecting children between 2 and 4 years old. Oral symptoms, such as mouth ulcers …

Antibody drug conjugates (ADCs) are an emerging class of treatments designed to improve
efficacy and decrease toxicity compared with other systemic therapies through the selective …

Background Oral mucositis (OM) is recognized as one of the most frequent debilitating
sequelae encountered by head and neck cancer (HNC) patients treated by radiotherapy …

Aim This study aimed to explore baseline nursing knowledge on assessment and
management of patients at risk for developing cancer therapy‐associated oral mucositis …

Pain is one of the most burdensome symptoms in people with cancer, and opioid analgesics
are considered the mainstay of cancer pain management. For this review, the authors …